European Patent Office

T 0334/92 (Benzodioxane derivatives/EISAI) du 23.03.1994

Identifiant européen de la jurisprudence
ECLI:EP:BA:1994:T033492.19940323
Date de la décision
23 mars 1994
Numéro de l'affaire
T 0334/92
Requête en révision de
-
Numéro de la demande
86110080.8
Classe de la CIB
C07D 319/20
Langue de la procédure
Anglais
Distribution
Distribuées aux présidents et aux membres des chambres de recours (B)
Téléchargement
Décision en anglais
Versions JO
Aucun lien JO trouvé
Autres décisions pour cet affaire
-
Résumés pour cette décision
-
Titre de la demande
1,4-benzodioxane derivatives, process for preparing them, pharmacological composition and use
Nom du demandeur
Eisai Co., Ltd.
Nom de l'opposant
-
Chambre
3.3.01
Sommaire
-
Dispositions juridiques pertinentes
European Patent Convention Art 56 1973
Mots-clés
Inventive step (yes) - closest prior art - determination of the technical problem
Exergue
I. The question of inventive step can only be objectively answered if an unrealistic approach is avoided. This implies that it is not appropriate to formulate an artificial and unrealistic technical problem which a skilled person, in practice, would not have considered (following T 495/91 and T 741/91). Therefore, a document that has been disregarded by those skilled in the art for more than 20 years and which has never been used during this period as a basis for further development, and which, moreover, is completely silent about the extent of the promised activity, which document, finally, does not even mention, let alone discuss, the relevant state of the art, so that the person skilled in the art is not in the position to recognise any technical advantage of these compounds in respect of that state of the art, does not represent the closest state of the art and cannot, therefore, be used for defining a realistic technical problem (No. 4.2 of the Reasons).
II. It is not permissible to ignore, for the purpose of defining the technical problem, technical evidence establishing technically useful properties of the claimed compounds, including the obtained level of activity (see No. 4.6 of the Reasons).

ORDER

For these reasons it is decided that

1. The decision under appeal is set aside.

2. The case is remitted to the Examining Division with the order to grant a patent with the two sets of claims submitted on 4 March 1994, after appropriate adaptation of the description.